Objectives The widespread use of proton pump inhibitors (PPIs) raised concerns on the safety of long-term use of these drugs. Community pharmacists have great responsibility of educating patients on ...

This study is committed to searching for inhibitors of deacetylase SIRT2 within the natural product database via computer-aided drug design techniques. A comprehensive computer-aided drug design ...

Objective To determine whether new users of proton pump inhibitors (PPIs) are at an increased risk of ... initiation Given that PPIs are one of the most commonly prescribed drug classes worldwide, and ...

Most of this was attributed to the results of the Celecoxib Long-term Arthritis Safety Study (CLASS ... effect profile of COX-2 inhibitors as more adverse drug reactions (ADRs) are being ...

So, the UK government is considering reclassing ketamine as a Class A drug. The Home Office asked the Advisory Council on the Misuse of Drugs to “carefully consider” the issue. Do you think ...

Ketamine was previously reclassified from class C to class B in 2014 ... Ketamine is a fast-acting drug that is used as medicine in animals and humans, so it has a legitimate purpose, as well ...

Rappta Therapeutics, a private biotech focused on developing anti-cancer drugs activating protein phosphatase 2A (PP2A), has announced an exclusive global license agreement with SpringWorks ...

Global Proton Pump Inhibitor Drug Market report (2025- 2032) research plays a pivotal role in modern business strategies by providing valuable insights into consumer behavior, preferences ...

Omeprazole, the prototype drug of PPIs, is metabolized primarily ... differences can be observed among the different proton pump inhibitors (PPIs), which might influence their clinical application.